Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Wulf

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|February 27, 2016
Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinibEvgenii Shumilov, Gerald Wulf, Philipp Ströbel, et al.
Transplantation and Cellular Therapy|August 5, 2024
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell TransplantationNico Gagelmann, Claudia Schuh, Robert Zeiser, et al.
Hemasphere|May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-upFrancesco d'Amore, Massimo Federico, Laurence de Leval, et al.
The Lancet. Oncology|May 16, 2014
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trialBertram Glass, Justin Hasenkamp, Gerald Wulf, et al.
American Journal of Hematology|May 14, 2024
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantationNico Gagelmann, Claudia Schuh, Sarah Flossdorf, et al.
Haematologica|November 4, 2017
<i>MDS1</i> and <i>EVI1</i> complex locus (MECOM): a novel candidate gene for hereditary hematological malignanciesTim Ripperger, Winfried Hofmann, Jan C Koch, et al.
Blood|September 19, 2013
High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysisDaniel Fürst, Carlheinz Müller, Vladan Vucinic, et al.
Haematologica|December 11, 2025
Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical studyKudret Kama, Hannes Treiber, Alexandra Kutilina, et al.
Frontiers in Cell and Developmental Biology|November 16, 2020
Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A MutationWener Li, Michael Stauske, Xiaojing Luo, et al.
Developmental Cell|July 11, 2006
In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring miceKarim Nayernia, Jessica Nolte, Hans W Michelmann, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|February 27, 2016
Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinibEvgenii Shumilov, Gerald Wulf, Philipp Ströbel, et al.
Transplantation and Cellular Therapy|August 5, 2024
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell TransplantationNico Gagelmann, Claudia Schuh, Robert Zeiser, et al.
Hemasphere|May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-upFrancesco d'Amore, Massimo Federico, Laurence de Leval, et al.
The Lancet. Oncology|May 16, 2014
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trialBertram Glass, Justin Hasenkamp, Gerald Wulf, et al.
American Journal of Hematology|May 14, 2024
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantationNico Gagelmann, Claudia Schuh, Sarah Flossdorf, et al.
Haematologica|November 4, 2017
<i>MDS1</i> and <i>EVI1</i> complex locus (MECOM): a novel candidate gene for hereditary hematological malignanciesTim Ripperger, Winfried Hofmann, Jan C Koch, et al.
Blood|September 19, 2013
High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysisDaniel Fürst, Carlheinz Müller, Vladan Vucinic, et al.
Haematologica|December 11, 2025
Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical studyKudret Kama, Hannes Treiber, Alexandra Kutilina, et al.
Frontiers in Cell and Developmental Biology|November 16, 2020
Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A MutationWener Li, Michael Stauske, Xiaojing Luo, et al.
Developmental Cell|July 11, 2006
In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring miceKarim Nayernia, Jessica Nolte, Hans W Michelmann, et al.
Pageof 14